Cargando…

Therapeutic potential of CRISPR/Cas9 gene editing in engineered T‐cell therapy

Cancer patients have been treated with various types of therapies, including conventional strategies like chemo‐, radio‐, and targeted therapy, as well as immunotherapy like checkpoint inhibitors, vaccine and cell therapy etc. Among the therapeutic alternatives, T‐cell therapy like CAR‐T (Chimeric A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Qianqian, Dong, Xuan, Xu, Qumiao, Zhu, Linnan, Wang, Fei, Hou, Yong, Chao, Cheng‐chi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675705/ https://www.ncbi.nlm.nih.gov/pubmed/31199589 http://dx.doi.org/10.1002/cam4.2257

Ejemplares similares

Rational guide RNA engineering for small-molecule control of CRISPR/Cas9 and gene editing
por: Liu, Xingyu, et al.
Publicado: (2022)

Functional interrogation of HOXA9 regulome in MLLr leukemia via reporter-based CRISPR/Cas9 screen
por: Zhang, Hao, et al.
Publicado: (2020)

CRISPR/Cas9 Delivery System Engineering for Genome Editing in Therapeutic Applications
por: Cheng, Hao, et al.
Publicado: (2021)

CRISPR-Cas genome editing tool: a narrow lane of cancer therapeutics with potential blockades
por: Bhatkar, Devyani, et al.
Publicado: (2020)

CRISPR/Cas9 mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials
por: Lin, Ann, et al.
Publicado: (2017)

Rapid genome editing by CRISPR-Cas9-POLD3 fusion
por: Reint, Ganna, et al.
Publicado: (2021)

Decorating chromatin for enhanced genome editing using CRISPR-Cas9
por: Chen, Evelyn, et al.
Publicado: (2022)

Discovery of potent and versatile CRISPR–Cas9 inhibitors engineered for chemically controllable genome editing
por: Song, Guoxu, et al.
Publicado: (2022)

Optimization of genome editing through CRISPR-Cas9 engineering
por: Zhang, Jian-Hua, et al.
Publicado: (2016)

Improved genome editing by an engineered CRISPR-Cas12a
por: Ma, Enbo, et al.
Publicado: (2022)

Opportunities for CRISPR/Cas9 Gene Editing in Retinal Regeneration Research
por: Campbell, Leah J., et al.
Publicado: (2017)

The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Inherited Diseases
por: Abdelnour, Sameh A., et al.
Publicado: (2021)

Off-target effects in CRISPR/Cas9 gene editing
por: Guo, Congting, et al.
Publicado: (2023)

A CRISPR Cas9 high-throughput genome editing toolkit for kinetoplastids
por: Beneke, Tom, et al.
Publicado: (2017)

Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option?
por: Mirgayazova, Regina, et al.
Publicado: (2020)

Development and characterization of anti‐glycopeptide monoclonal antibodies against human podoplanin, using glycan‐deficient cell lines generated by CRISPR/Cas9 and TALEN
por: Kaneko, Mika K., et al.
Publicado: (2017)

A single-cell approach to engineer CD8+ T cells targeting cytomegalovirus
por: Wang, Fei, et al.
Publicado: (2020)

Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing
por: Dimitri, Alexander, et al.
Publicado: (2022)

Current applications and future perspective of CRISPR/Cas9 gene editing in cancer
por: Wang, Si-Wei, et al.
Publicado: (2022)

CRISPR/Cas9 or prime editing? – It depends on…
por: Schenke, Dirk
Publicado: (2020)

Genome Editing in Cotton with the CRISPR/Cas9 System
por: Gao, Wei, et al.
Publicado: (2017)

CRISPR-Cas9 DNA Base-Editing and Prime-Editing
por: Kantor, Ariel, et al.
Publicado: (2020)

Enhancing Understanding of the Visual Cycle by Applying CRISPR/Cas9 Gene Editing in Zebrafish
por: Ward, Rebecca, et al.
Publicado: (2018)

Development of a CRISPR/Cas9 System for Methylococcus capsulatus In Vivo Gene Editing
por: Tapscott, Timothy, et al.
Publicado: (2019)

A high-throughput small molecule screen identifies farrerol as a potentiator of CRISPR/Cas9-mediated genome editing
por: Zhang, Weina, et al.
Publicado: (2020)

Retroelement Insertion in a CRISPR/Cas9 Editing Site in the Early Embryo Intensifies Genetic Mosaicism
por: Jeon, Jeehyun, et al.
Publicado: (2019)

CRISPR/Cas9: A revolutionary genome editing tool for human cancers treatment
por: Akram, Fatima, et al.
Publicado: (2022)

Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
por: Zhang, Song, et al.
Publicado: (2021)

Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies
por: Papizan, James B., et al.
Publicado: (2021)

CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeutics
por: Bhardwaj, Shanu, et al.
Publicado: (2021)

Recent advances in therapeutic CRISPR-Cas9 genome editing: mechanisms and applications
por: Zhou, Lifang, et al.
Publicado: (2023)

Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide
por: Wang, Hong-Xia, et al.
Publicado: (2018)

Allele-specific genome editing using CRISPR–Cas9 is associated with loss of heterozygosity in diploid yeast
por: Gorter de Vries, Arthur R, et al.
Publicado: (2019)

Targeted genome and epigenome editing using engineered TALE and CRISPR/Cas9 technologies
por: Gersbach, Charles A
Publicado: (2014)

Engineering of CRISPR-Cas12b for human genome editing
por: Strecker, Jonathan, et al.
Publicado: (2019)

Dataset on nicotine-free, nontransgenic tobacco (Nicotiana tabacuml.) edited by CRISPR-Cas9
por: Schachtsiek, Julia, et al.
Publicado: (2019)

SWISS: multiplexed orthogonal genome editing in plants with a Cas9 nickase and engineered CRISPR RNA scaffolds
por: Li, Chao, et al.
Publicado: (2020)

Inducible in vivo genome editing with CRISPR/Cas9
por: Dow, Lukas E, et al.
Publicado: (2015)

Efficient Mitochondrial Genome Editing by CRISPR/Cas9
por: Jo, Areum, et al.
Publicado: (2015)

CRISPR/Cas9: Transcending the Reality of Genome Editing
por: Chira, Sergiu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3ooun6tidckl51ngicl7bqdccd